熱門資訊> 正文
ALT、CYCC和DB均为盘前输家
2024-04-29 20:17
- Losers: Clever Leaves Holdings (CLVR) -61% announces Voluntary Delisting and SEC Deregistration.
- Addex Therapeutics Ltd (ADXN) -52% provides update on ADX71149 phase 2 Epilepsy study.
- Cyclacel Pharmaceuticals (CYCC) -21%.
- Nature Wood Group Ltd (NWGL) -15%.
- mF International Ltd (MFI) -14%.
- Biodexa Pharmaceuticals (BDRX) -11%.
- Avenue Therapeutics (ATXI) -11% announces exercise of warrants for $4.4 Million in gross proceeds.
- reAlpha Tech Corp. (AIRE) -10%.
- Nuzee (NUZE) -9%.
- Deutsche Bank (DB) -8%.
- Blue Hat Interactive Entertainment Technology (BHAT) -8%.
- Lichen China Ltd (LICN) -7%.
- Altimmune (ALT) -6%.
- Hub Cyber Security Ltd (HUBC) -5%.
- Daqo New Energy Corp (DQ) -5% after Q1 earnings release.
More on pre-market losers & stocks.
- Deutsche Bank AG (DB) Q1 2024 Earnings Call Transcript
- Deutsche Bank May Knock Q1 Estimates Out Of The Park
- Buy Altimmune's Potential Market Disruption With Pemvidutide
- Deutsche Bank reports 10%Y/Y growth in net profit; to increase share repurchases, dividends by at least 50% in 2024
- Deutsche Bank Q1 2024 Earnings Preview
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。